CSF1R inhibition in amyloid mouse models also reduced ICCs of TSPO-PET compared to mice with amyloidosis and intact microglia, although depletion of microglia was incomplete (66%) after seven weeks of treatment. This evidence concerns the gene TSPO and amyloidosis.